Quality & Regulatory Compliance

Quality & Regulatory Compliance

Category: Bio-Pharmaceuticals

Category: Bio-Pharmaceuticals

Product: Parathyroid Hormone (PTH or Teriparatide)

Product: Parathyroid Hormone (PTH or Teriparatide)

• Our PTH material is produced in compliance with GMP guidelines and undergoes rigorous quality testing, including:

• Purity and identity verification (HPLC, Mass Spectrometry)

• Endotoxin testing (LAL assay)

• Sterility and microbial contamination screening

Product: Recombinant Human Albumin

Product: Recombinant Human Albumin

• Manufactured under cGMP guidelines

• Complies with USP, EP, and JP standards

• Endotoxin and sterility tested

• DMF available upon request

Product: Ranibizumab

Product: Ranibizumab

• Comprehensive CMC documentation for regulatory submissions

• Compliance with CDSCO, EMA, and ICH guidelines

Stability studies as per regulatory requirements

Product: Human Growth Hormone

Product: Human Growth Hormone

• cGMP, CDSCO, EMA, and ICH guidelines.

Product: PEG-Asparaginase

Product: PEG-Asparaginase

• Manufactured in cGMP-compliant facilities

• Stringent quality control and batch-to-batch consistency

• Regulatory support available for global market approvals

Category: Bio-Pharmaceuticals Drug Products (under pipeline)

Category: Bio-Pharmaceuticals Drug Products (under pipeline)

Product: Recombinant Human Parathyroid Hormone (rhPTH)

Product: Recombinant Human Parathyroid Hormone (rhPTH)

• Lorven manufactured following strict cGMP guidelines and in compliance with CDSCO and EMA regulations.

Product: Recombinant Human Albumin (rDNA Origin)

Product: Recombinant Human Albumin (rDNA Origin)

• Produced under cGMP-compliant facilities.

• Meets regulatory standards such as CDSCO, and EMA.

• Free from animal-derived components and prion contamination.

Category: Synthetic Chemistry (Pharmaceutical Intermediates and API’s)

Category: Synthetic Chemistry (Pharmaceutical Intermediates and API’s)

Product: Tapentadol-HCl

Product: Tapentadol-HCl

• Tapentadol was first approved for the US market in 2008. The safety and efficacy data of tapentadol for the treatment of acute and chronic pain in adults has been well established

Product: Sitagliptin-Phosphate

Product: Sitagliptin-Phosphate

• Sitagliptin was approved by the US Food and Drug Administration (FDA) in October 2006, and is sold under the brand name Januvia. In April 2007, the FDA approved an oral combination of sitagliptin/metformin sold under the brand name Janumet.

Product: Phenylephrine-HCl

Product: Phenylephrine-HCl

• Phenylephrine received FDA approval for over-the-counter use in the 1970s, its popularity surged in 2005 after legislation moved products that use a similar decongestant, pseudoephedrine.

Product: Apixaban

Product: Apixaban

• Apixaban is a novel oral anticoagulant approved by the US Food and Drug Administration (FDA) in 2012 for use in patients with nonvalvular atrial fibrillation to reduce the risk of stroke and blood clots.

Product: Pregabalin

Product: Pregabalin

• Pregabalin was approved by the United States Food and Drug Administration (FDA) in 2004. Pregabalin is utilized for neuropathic pain and seizures.

Lorven biologics

Innovating today for a better tomorrow

Innovating today for a better tomorrow

Innovating today for a better tomorrow

Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.

Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.

Based in Hyderabad, IN

Based in Hyderabad, IN

COMPANY

OUR PRODUCTS

KEY SERVICES

SUPPORT

sOCIALS

© 2025 Lorven Biologics. All Rights Reserved.

Empowering Science, Enriching Lives.